| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | 28-Feb-07 | | Total Revenue | 2,585 | 2,851 | 2,351 | | Cost of Revenue | 1,487 | 1,637 | 1,512 | | | Gross Profit | 1,097 | 1,213 | 839 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,045 | 2,057 | 2,152 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (948) | (844) | (1,312) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 18 | 1 | 12 | | Earnings Before Interest And Taxes | (929) | (843) | (1,300) | | Interest Expense | 222 | 193 | 150 | | Income Before Tax | (1,152) | (1,036) | (1,450) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,152) | (1,036) | (1,450) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,152) | (1,036) | (1,450) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,152) | ($1,036) | ($1,450) |
|
0.29% Nasdaq 0.00%
Income Statement
